Navigation Links
The Japanese Cancer Association and Debiopharm Group Present Doctors Oshima and Tanaka with the 2012 'JCA-Mauvernay Award' for their Innovative and Outstanding Cancer Research
Date:9/21/2012

is studies indicate that cooperation of Wnt activation and PGE2 associated inflammation is essential for gastric cancer development. He has shown the role of both inflammation and Wnt pathway separately in gastric cancer by using his mouse model. These findings will contribute significantly to understanding the biological in vivo mechanism of gastric cancer development.

Dr Shinji Tanaka is an associate professor in the Department of Hepato-Biliary-Pancreatic Surgery at the Tokyo Medical and Dental University.

His work focuses on using clinical tissue samples to analyse refractory digestive cancers including hepato-biliary, pancreatic, oesophageal, and scirrhous gastric carcinomas, which have a poor outcome even after curative surgical resection.

His lab has analysed over 1000 clinical samples from surgically resected tissue and isolated 28 novel cancer related genes. This has allowed them to clarify several oncogenic mechanisms.

Dr Tanaka isolated a novel angiogenic switch gene called angiopoietin-2. Angiogenic switch is a hallmark of cancer progression in-vivo. Recent clinical trials of the anti-angiopoietin-2 peptide revealed it as a promising agent to treat advanced cancers that are resistant to VEGF inhibitors.

His studies have demonstrated that oxidative stress in the host tissues is the only predictive factor of the recurrence after curative resection in hepatocellular carcinoma. And more recently he identified one type of agent specifically targeting cancer stem cell. This discovery should lead to a promising approach for radical cure of pancreatic cancer.

About Debiopharm Group™

Debiopharm Group™ (Debiopharm) is a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs. The group in-licenses, develops and/or co-develops promising biological and small molecule drug candidates having reached clinical d
'/>"/>

SOURCE The Debiopharm Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Japanese Market for Orthopedic Soft Tissue Repair & Sports Medicine
2. Hologic, Inc. Marks Breast Cancer Awareness Month by Ringing the Opening Bell at NASDAQ and Taking 3D Mammography on the Road
3. Male Menopause, Testosterone, Prostate Cancer; The Connection Between Them
4. US Cancer Vaccine Market Analysis
5. Jennerex Presents Positive Clinical Data from Phase 2 Trial of JX-594 in Sorafenib-Refractory Liver Cancer Patients
6. Onconome Announces Results Of Blood Test For Colorectal Cancer; Further Trials Underway
7. Prostate Cancer: The End of Life As Men Know It?
8. Agendia Announces Five Studies in Breast Cancer for Presentation at the American Society of Clinical Oncology 2012 Breast Cancer Symposium
9. Aethlon Medical Discloses MD Anderson Cancer Center Presentation
10. Frost & Sullivan Lauds IncellDx for Developing a Novel, Non-invasive Method for Cervical Cancer Testing
11. Cardinal Health Specialty Solutions, Health Alliance Plan Work With Michigan Oncologists to Improve Quality, Curb Costs of Cancer Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 2014  RESMED INC. (NYSE: RMD ) today ... year ended June 30, 2014 results on Thursday, July 31, ... press release with ResMed,s results will be issued after 1:00 ... webcast to discuss operating results and future outlook. ... US Pacific Time and the live webcast of the call ...
(Date:7/10/2014)... Mass. , July 10, 2014  Decision ... of surveyed infectious disease (ID) specialists are willing ... Company,s Orbactiv (oritavancin) for use as OPAT, approximately ... prescribe these agents to their hospital inpatients. However, ... of OPAT patients are initiated on OPAT following ...
(Date:1/15/2014)... -- ChinaMarketResearchReports.com adds "China Orthopedic Instrument Industry Report, 2013-2015" ... (Photo: http://photos.prnewswire.com/prnh/20140115/MN46792 ) Benefiting from aging ... China,s orthopedic instrument industry has seen rapid ... from 3.28 billion yuan in 2006 to 9.85 billion ...
Breaking Medicine Technology:ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3
... ... ... ... ...
... ... ... ... ...
Cached Medicine Technology:Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 2Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 3Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 4Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 5Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 6Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 7Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 8Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 9Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 10Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 11Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 12Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 13Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 14Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 15Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 16Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 17Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 18Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 19Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 20Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy 2Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy 3Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy 4Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy 5Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy 6Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy 7Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy 8
(Date:7/11/2014)... (PRWEB) July 11, 2014 Los ... announces that he uses mini and full mouth implants ... the defining feature that distinguishes dental implants from other ... addition to the crowns. This alone prevents the long-term ... also offer advantages related to comfort, appearance and systemic ...
(Date:7/11/2014)... Maureen Salamon HealthDay ... -- For the millions of women who can,t cough, ... testing a treatment that uses stem cells to regenerate ... European researchers found that injecting stem cells isolated from ... in all participants within a year. Stress ...
(Date:7/11/2014)... July 11, 2014 Recent research findings regarding ... the atmosphere, and how water affects human bodies. That was ... Pollack, during an interview on the Sharon Kleyne Hour Power ... , Gerald Pollack, PhD, is a Professor of Bioengineering ... Fourth Phase of Water (Ebner & Sons, 2013). ...
(Date:7/11/2014)... July 11, 2014 Shoulder instability is ... of return to play has not been regularly determined ... Orthopaedic Society for Sports Medicine’s ( AOSSM ) Annual ... is approximately 90 percent no matter what the stabilization ... success rate of return to play following shoulder stabilization ...
(Date:7/11/2014)... reconstructions occur more than 200,000 times a year, but ... ligament may determine how long you stay in the ... Annual Meeting of the American Orthopaedic Society of Sports ... that in a young athletic population, allografts (tissue harvested ... (tissue harvested from the patient)," said Craig R. Bottoni, ...
Breaking Medicine News(10 mins):Health News:Dental Implant Dentist, Kevin Sands DDS, Now Uses Mini and Full Mouth Implants to Replace Missing Teeth 2Health News:Stem Cells May Ease Urinary Incontinence, Study Says 2Health News:Stem Cells May Ease Urinary Incontinence, Study Says 3Health News:Recent Fourth Phase Water Discoveries Alter Basic Understanding of Life, Claims Researcher on Sharon Kleyne Hour 2Health News:Recent Fourth Phase Water Discoveries Alter Basic Understanding of Life, Claims Researcher on Sharon Kleyne Hour 3Health News:Stabilizing Shoulder Surgery Helps NFL Players Return to the Game 2Health News:ACL reconstructions may last longer with autografts 2
... spikes a high fever, sometimes as high as 104 or ... emergency room, the hospital runs test after test, specialists are ... though no one knows how many go through ... arent accompanied by any obvious symptoms and dont respond to ...
... BUFFALO, N.Y. -- For a rich source of stem cells ... clinicians may one day look no further than the hair ... this month by University at Buffalo engineers. , ... new blood vessels or regenerating new skin tissue using stem ...
... Governor Edward G.,Rendell today released the text of his ... deadline for MCare fund assessment payments:, Dear Health ... that the state was in a unique,position to extend ... to affordable health care for hundreds of thousands of ...
... THE GOVERNMENT CURB AN OVERLY AGGRESSIVE VACCINATION SCHEDULE ... 28 Parents of children who,regressed into autism ... health officials may at last be catching on ... article published on Huffington Post by investigative journalist,David ...
... currently Dean of Research and Graduate Education in the ... University (JHU), has,been appointed Chief Executive Officer and Executive ... the,position on July 1, 2008. A published author in ... JHU and at JHU has served,as department chair of ...
... warn doctors early to change treatments , , FRIDAY, March ... they may have found a blood marker that denotes ... The researchers found an increase in the CD163+/CD16+ monocyte ... virus (HIV), according to a study published in the ...
Cached Medicine News:Health News:Mysterious fevers of unknown origin: Could surgery be a cure? 2Health News:Stem cells from hair follicles may help 'grow' new blood vessels 2Health News:Governor Rendell Writes to Physicians to Explain MCare Fund Assessment Deadline 2Health News:MITOCHONDRIAL DYSFUNCTION, VACCINES AND AUTISM: 1 in 50 Children Could Be at Risk 2Health News:Hauptman-Woodward Appoints Dr. Eaton Lattman CEO and Executive Director 2Health News:Hauptman-Woodward Appoints Dr. Eaton Lattman CEO and Executive Director 3Health News:Biomarker May Signal HIV Progression 2
The major innovation in posterior stabilized (PS) knee design. Improve patellofemoral kinematics. Reduce wear rate potential. Increase resistance to posterior tibial dislocation. Achieve at least 120...
... provides the adaptability surgeons need to make ... other way around. The wide selection of ... components allow surgeons to address the unexpected ... all with one instrument set. For cruciate ...
... minimally invasive uni-compartmental knee replacement is an ... surgery. This procedure provides patients with a ... knee.,Arthritis of the knee often results in ... quality of life and even depression. Orthopedic ...
... The Genesis II® Total Knee System will ... far more is possible with less - ... while fully addressing both clinical and cost ... these design goals, giving surgeons creative solutions ...
Medicine Products: